<i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>

Monkeypox (Mpox), an emerging zoonotic infectious disease caused by the monkeypox virus (MPXV), has become an escalating global health threat. A wave of outbreaks began in 2022 and continued through the end of 2024. Currently, no vaccines or FDA-approved specific treatments exist for MPXV, making t...

Full description

Saved in:
Bibliographic Details
Main Authors: Phuoc Huynh, Ba-Hai Nguyen, Quan Ke Thai
Format: Article
Language:English
Published: Vietnam Ministry of Science and Technology 2025-08-01
Series:Vietnam Journal of Science, Technology and Engineering
Subjects:
Online Access:https://vietnamscience.vjst.vn/index.php/vjste/article/view/1310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849770379783962624
author Phuoc Huynh
Ba-Hai Nguyen
Quan Ke Thai
author_facet Phuoc Huynh
Ba-Hai Nguyen
Quan Ke Thai
author_sort Phuoc Huynh
collection DOAJ
description Monkeypox (Mpox), an emerging zoonotic infectious disease caused by the monkeypox virus (MPXV), has become an escalating global health threat. A wave of outbreaks began in 2022 and continued through the end of 2024. Currently, no vaccines or FDA-approved specific treatments exist for MPXV, making the discovery of effective antiviral drugs crucial. The A48R protein, a thymidylate kinase (TK), is recognised as a promising target for MPXV drug development due to its distinctive active site structure compared with the human homolog. Hypericum sampsonii Hance, a traditional medicinal herb from the Guttiferae family, has demonstrated various biological activities, including antiviral properties. By leveraging the natural compounds derived from H. sampsonii, this study aimed to identify potential inhibitors of the MPXV-TK protein. Molecular docking and dynamics simulations revealed two compounds, LTS0126561 and LTS0259892, with strong affinity for the TK active site. In silico pharmacokinetic and toxicological assessments indicated that both compounds are suitable candidates for oral drug development. These identified compounds represent a solid foundation for developing antiviral agents against MPXV and other Orthopoxviruses. However, further experimental validation of these lead compounds is required to confirm their predicted antiviral activities.
format Article
id doaj-art-d129d3d6c2434b8fa0e4b76353d7b98f
institution DOAJ
issn 2525-2461
2615-9937
language English
publishDate 2025-08-01
publisher Vietnam Ministry of Science and Technology
record_format Article
series Vietnam Journal of Science, Technology and Engineering
spelling doaj-art-d129d3d6c2434b8fa0e4b76353d7b98f2025-08-20T03:03:02ZengVietnam Ministry of Science and TechnologyVietnam Journal of Science, Technology and Engineering2525-24612615-99372025-08-0110.31276/VJSTE.2025.0012<i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>Phuoc HuynhBa-Hai NguyenQuan Ke Thai Monkeypox (Mpox), an emerging zoonotic infectious disease caused by the monkeypox virus (MPXV), has become an escalating global health threat. A wave of outbreaks began in 2022 and continued through the end of 2024. Currently, no vaccines or FDA-approved specific treatments exist for MPXV, making the discovery of effective antiviral drugs crucial. The A48R protein, a thymidylate kinase (TK), is recognised as a promising target for MPXV drug development due to its distinctive active site structure compared with the human homolog. Hypericum sampsonii Hance, a traditional medicinal herb from the Guttiferae family, has demonstrated various biological activities, including antiviral properties. By leveraging the natural compounds derived from H. sampsonii, this study aimed to identify potential inhibitors of the MPXV-TK protein. Molecular docking and dynamics simulations revealed two compounds, LTS0126561 and LTS0259892, with strong affinity for the TK active site. In silico pharmacokinetic and toxicological assessments indicated that both compounds are suitable candidates for oral drug development. These identified compounds represent a solid foundation for developing antiviral agents against MPXV and other Orthopoxviruses. However, further experimental validation of these lead compounds is required to confirm their predicted antiviral activities. https://vietnamscience.vjst.vn/index.php/vjste/article/view/1310A48R protein<i>Hypericum sampsonii</i>molecular dockingmolecular simulationsmonkeypox virusnatural compounds
spellingShingle Phuoc Huynh
Ba-Hai Nguyen
Quan Ke Thai
<i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>
Vietnam Journal of Science, Technology and Engineering
A48R protein
<i>Hypericum sampsonii</i>
molecular docking
molecular simulations
monkeypox virus
natural compounds
title <i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>
title_full <i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>
title_fullStr <i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>
title_full_unstemmed <i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>
title_short <i>In silico</i> identification of potential anti-monkeypox virus agents from <i>Hypericum sampsonii</i>
title_sort i in silico i identification of potential anti monkeypox virus agents from i hypericum sampsonii i
topic A48R protein
<i>Hypericum sampsonii</i>
molecular docking
molecular simulations
monkeypox virus
natural compounds
url https://vietnamscience.vjst.vn/index.php/vjste/article/view/1310
work_keys_str_mv AT phuochuynh iinsilicoiidentificationofpotentialantimonkeypoxvirusagentsfromihypericumsampsoniii
AT bahainguyen iinsilicoiidentificationofpotentialantimonkeypoxvirusagentsfromihypericumsampsoniii
AT quankethai iinsilicoiidentificationofpotentialantimonkeypoxvirusagentsfromihypericumsampsoniii